Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Accenture
Merck
Cerilliant
Chinese Patent Office
Teva
Julphar
Boehringer Ingelheim
Medtronic
Dow

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,674,860

« Back to Dashboard

Summary for Patent: 5,674,860
Title: Combination of a bronchodilator and a steroidal anti-inflammatory drug for the treatment of respiratory disorders
Abstract:Effective amounts of formoterol and/or a physiologically acceptable salt and/or solvate thereof and budesonide are used in combination for simultaneous, sequential or separate administration by inhalation in the treatment of an inflammatory respiratory disorder, such as asthma.
Inventor(s): Carling; Christer Carl Gustav (Dalby, SE), Trofast; Jan William (Lund, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/317,407
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 5,674,860

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,674,860

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
91311761Dec 18, 1991

International Patents Family Members for US Patent 5,674,860

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 213946 ➤ Subscribe
Australia 3085892 ➤ Subscribe
Australia 673660 ➤ Subscribe
Canada 2123909 ➤ Subscribe
Canada 2356145 ➤ Subscribe
Czech Republic 288032 ➤ Subscribe
Czech Republic 291455 ➤ Subscribe
Czech Republic 9401434 ➤ Subscribe
Germany 10299033 ➤ Subscribe
Germany 69232462 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Cipla
Moodys
AstraZeneca
Accenture
Express Scripts
Boehringer Ingelheim
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot